1. Home
  2. ANVS vs ALAR Comparison

ANVS vs ALAR Comparison

Compare ANVS & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • ALAR
  • Stock Information
  • Founded
  • ANVS 2008
  • ALAR 2013
  • Country
  • ANVS United States
  • ALAR Israel
  • Employees
  • ANVS N/A
  • ALAR N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • ALAR Computer Software: Prepackaged Software
  • Sector
  • ANVS Health Care
  • ALAR Technology
  • Exchange
  • ANVS Nasdaq
  • ALAR Nasdaq
  • Market Cap
  • ANVS 92.6M
  • ALAR 94.0M
  • IPO Year
  • ANVS 2020
  • ALAR 2018
  • Fundamental
  • Price
  • ANVS $5.04
  • ALAR $11.28
  • Analyst Decision
  • ANVS Strong Buy
  • ALAR Strong Buy
  • Analyst Count
  • ANVS 6
  • ALAR 2
  • Target Price
  • ANVS $29.67
  • ALAR $24.00
  • AVG Volume (30 Days)
  • ANVS 294.5K
  • ALAR 227.0K
  • Earning Date
  • ANVS 11-08-2024
  • ALAR 11-25-2024
  • Dividend Yield
  • ANVS N/A
  • ALAR N/A
  • EPS Growth
  • ANVS N/A
  • ALAR N/A
  • EPS
  • ANVS N/A
  • ALAR 0.10
  • Revenue
  • ANVS N/A
  • ALAR $31,561,000.00
  • Revenue This Year
  • ANVS N/A
  • ALAR $22.15
  • Revenue Next Year
  • ANVS N/A
  • ALAR $11.59
  • P/E Ratio
  • ANVS N/A
  • ALAR $11.82
  • Revenue Growth
  • ANVS N/A
  • ALAR 40.80
  • 52 Week Low
  • ANVS $4.53
  • ALAR $4.41
  • 52 Week High
  • ANVS $22.49
  • ALAR $46.69
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 32.21
  • ALAR 40.32
  • Support Level
  • ANVS $4.76
  • ALAR $11.29
  • Resistance Level
  • ANVS $6.37
  • ALAR $12.34
  • Average True Range (ATR)
  • ANVS 0.50
  • ALAR 0.67
  • MACD
  • ANVS -0.05
  • ALAR -0.08
  • Stochastic Oscillator
  • ANVS 14.45
  • ALAR 9.68

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.

Share on Social Networks: